HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

Bibliographic Details
Main Authors: Ribeiro, J. R., Schorl, C., Yano, N., Romano, N., Kim, K. K., Singh, R. K., Moore, R. G.
Format: Online
Language:English
Published: BioMed Central 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869286/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869286/

Similar Items